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ABSTRACT
Approximately 83% of the world’s population is seropositive for human cytomegalovirus
(HCMV) and will endure lifelong latency. An immunocompromising disease such as HIV/AIDS
increases susceptibility to reactivation and HCMV diseases. If an AIDS patient’s CD4+ T cell
count falls below 50 cells/μL of peripheral blood, HCMV is reactivated which causes a sightthreatening retinitis. The disease affects up to 42% of AIDS patients and causes retinal necrosis.
To further investigate the mechanisms of AIDS-related HCMV retinitis we studied RIPK3
stimulation in HCMV-infected ARPE-19 cells under oxidative stress, through pursuit of two
experimental hypotheses: (1) HCMV-infected ARPE-19 cells will upregulate RIPK3 in the
presence of oxidative stress induced by H2O2 and (2) HCMV-infected MRC-5 cells will not
express RIPK3 stimulation in the presence of oxidative stress induced by H2O2. Our data
suggests that RIPK3 stimulation presents a cell-specific dose-dependent response to H2O2
concentrations in ARPE-19 cells during HCMV infection.
INDEX WORDS: Human cytomegalovirus (HCMV), Oxidative stress, RIPK3, AIDS-related
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1

INTRODUCTION

“Do not allow your mind to be imprisoned by majority thinking. Remember that the limits of
science are not the limits of imagination”- Patricia Bath, MD

Human cytomegalovirus (HCMV) is a ubiquitous, species-specific virus that
establishes lifelong latency in bone marrow and monocytes [47]. As an opportunistic pathogen,
HCMV affects various organs causing a variety of diseases including encephalitis, colitis,
hepatitis, pneumonitis, and retinitis [13]. HCMV is a double-stranded DNA (dsDNA) virus
within the Herpesviridae family under the subfamily of Betaherpesvirinae [2]. The viral dsDNA
lies within an icosahedral capsid, composed of 162 capsomeres, adjacent to a viral tegument and
surrounded by a viral envelope [58]. Structurally, the capsid consists of four virus-encoded
proteins critical for viral replication, triplex monomer (TR1), triplex dimer (TR2), major capsid
protein (MCP), and the small capsid protein (SCP) [5, 58, 61]. Along with a specialized pore on
the single side of the icosahedron, known as a portal protein (PORT), to act as a channel for viral
genome release [5]. The PORT is essential to package viral DNA and utilizes two gene products,
UL89 and UL56, to help release viral genome [58,61]. The viral genome is comprised of over 25
membrane glycoproteins and over 230 genes [6-10]. The five essential glycoproteins for HCMV
replication, are gB, gM:gN, gH:gL, while gB and gH:gL allow for viral entry [58].
The viral DNA enters through the nuclear pore of a host cell. Following viral DNA entry,
the viral genome replicates transcribing its DNA sequentially through a regulated cascade of
immediate-early (IE) genes, early (E) genes, and late genes (L). Within minutes of viral
infection, the IE genes are first transcribed to regulate the expression for early enzymes [58]. The
IE gene is essential for viral DNA replication and encoded by gene product IE1 [3]. The IE genes
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regulate the expression of early enzymes for DNA replication through early genes. New virions
enclosed in vesicles are transported to the plasma membrane, where the vesicles fuse with the
host’s membrane and release viral progeny. In fibroblasts cells, such as MRC-5 cells (human
lung fibroblasts) in vitro studies, this process lasts longer compared to RPE cells with an elapsed
time of up to two days [19,55].
HCMV has shown to infect many cell types and is capable of replicating in epithelial
cells, macrophages, endothelial cells, hepatocytes, smooth muscle, stromal cells, progenitor cells,
and fibroblasts [17,18]. Among the cell types, HCMV expresses viral tropism for fibroblasts,
seen in MRC-5 cells [13], and epithelial cells, seen in ARPE-19 cells [58,59,19,55]. HCMV
enters epithelial cells and endothelial cells through endocytosis, while it enters fibroblasts
through direct fusion of the viral envelope to the host’s cell membrane. After viral entry HCMV
begins to recruit host cell machinery through the host cell’s endosomes, endoplasmic reticulum
(ER), and the ER-Golgi intermediate compartment (ERGIC) after binding to the host cell surface
receptor [4]. This proceeds down the cascade regulation to initiate IE, E, and L as mentioned
earlier to develop virions [6].
Virions are infectious virus particles and dense bodies enclosed in a lipid bilayer
envelope derived from ERGIC [12]. Within a virion are 23 viral glycoproteins. Presently, three
viral glycoproteins are essential for attachment to allow for viral entry, gB and gH:gL, while
gM:gN allow for maturation of the virus [12]. Additional help may also come from pUS16 if
gH:gL is silent or deleted [12]. The viral tegument (or matrix) of HCMV packs in-between the
nucleocapsid and the envelope containing a minimum of 32 virally-encoded tegument
glycoproteins, including the host’s protein RNA [3, 58]. Numerous tegument proteins are
phosphorylated (pp), such as viral protein pp65, and can provoke an immune response reactivity
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in a host [4]. Pp65 targets major histocompatibility class (MHC) class I CD8 T cells and MHC
class II CD4 T cells [58]. Immediately upon viral entry, pp65 localizes to the nucleus of the
infected cell. This localization allows pp65 to modulate the immune system by reducing the
interferon response at the site of infection and enter its latent state. Once HCMV enters a host
cell, it will establish latency for the remainder of the host’s life [58]. Latency entails long-term
maintenance of viral genomes in an immunocompetent host with sustained viral genomes in
hematopoietic cells and in CD4+ T cells.
An overview of HCMV replication and life cycle in Figure 1.

Figure 1. HCMV replication cycle within a host cell. HCMV utilizes its cellular receptors gB
[and the understood gH:gL protein complex] to activate transcription factors NF-κB and Sp1 for
entry into a host cell. Upon entry, the virus releases viral DNA into the cytoplasm of the host
cell, which will be transported to the host nucleus. Within the nucleus, HCMV utilizes the host’s
transcription factors to code for its own DNA polymerase and replicate its viral DNA. The viral
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components and DNA are packaged in the virion envelope, and the infectious viral particles are
released from the host cell [11].
HCMV can cause congenital infections, which may lead to the death of a fetus or
developmental abnormalities in approximately 0.2% to 2% of the United States infant population
each year [58, 59]. The percentage of women in America of childbearing age at risk for infection
is 86% and the percentage of the global population is 86%. Primary HCMV-infection is often
acquired during childhood through saliva, breast milk, or urine. Moreover, other ways to contract
HCMV is through genital secretions, usually during adolescence or adulthood, through sexual
intercourse or in cases of childhood rape [14]. Upon primary infection, there is viremia. A
leukocyte-associated viremia that allows active HCMV to remain in the blood. Infectious viral
particles shed through urine, saliva, or semen for months or years, even in a functional immune
system [51]. However, primary infection generally causes asymptomatic symptoms in healthy
immunologically normal children and adults [15]. Their primary infection is under control by
innate and adaptive immune responses. If primary infection of HCMV is acquired as an adult, a
nonspecific illness will transpire [16]. The illness will produce a fever lasting 1–3 weeks
associated with transient lymphocytosis and a developing abnormal liver [16].
In addition to primary infection, HCMV travels to the bone marrow to establish latency
and remains undetected by the immune system for the duration of the host’s life. HCMV infects
CD34+ myeloid progenitor cells in the bone marrow but is blocked to transcribe into more
virions when bound to the IE promotor gene. This viral block puts HCMV in the latency stage
within the bone marrow expressing only a limited viral load within the nucleus.
During chronic infection, low viral loads are shed continuously from the host for an
extended period of time. The length of time the virus sheds depends on the health of the host.
Chronic virus shedding may branch off from the primary infection or may occur after
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reactivation of the virus in a latent stage. Latent infection in cells allows HCMV to travel
throughout the body and is the main contributor of systemic infection if the virus reactivates
[58]. Reactivation of a latent virus is due to a weakened immune system [15]. This mechanism
favors the viral life span of HCMV within the host by exiting latent virus reservoirs within the
host to promote viral spread amongst new hosts. If an individual is no longer an immunologically
normal person the virus will leave the latency stage and proliferate. AIDS patients are an
example of individuals who have acquired an impaired immune system and are no longer
immunologically normal.

1.1

AIDS-Related Human Cytomegalovirus Retinitis
When the immune system in a host becomes weakened due to HIV infection, it puts a

host in danger of acquiring an opportunistic infection such as HCMV. HCMV is an opportunistic
infection that travels to the retina, liver, fibroblasts, and GI tract [47]. The global percentage of
people currently infected with HCMV has increased from approximately 80% to 83% [20].
Activated HCMV will cause a cytokine driven inflammatory response that will continue to drive
the cell to differentiate and reactivate the virus locally or systemically. If left untreated, HCMV
will remain active and cause varied diseases such as encephalitis, colitis, hepatitis, pneumonitis,
and retinitis [59]. In AIDS patients, HCMV-infection can develop into a sight-threatening
disease known as AIDS- related cytomegalovirus retinitis. The progression of AIDS, is
distinguished after the host’s CD4+ T cell count, falls below 200 cells/μL of peripheral blood. If
the host does not respond to antiretroviral therapy (ART) or doesn’t have access to ART, their
CD4+T cells will continue to drop. When the host’s CD4+ T cell count falls below 50 cells/μL of
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peripheral blood HCMV will reactivate in a seropositive individual and cause AIDS-related
human cytomegalovirus retinitis [15,21].
Due to AIDS-related HCMV retinitis affecting up to 42% of AIDS patients [14], our
work focuses on the effects HCMV has on the retina. HCMV travels to the retina in infected
macrophages and monocytes through the retinal blood vessels to proliferate in the retinal
pigmented epithelium (RPE), illicit an inflammatory response, and cause retinal destruction
[15,21]. The damaged RPE is caused by enlarging lesions in the retina of individual foci that lead
to vision loss in an average of six months to a year [15,21]. Failure to treat this disease through
antivirals such as ganciclovir, valganciclovir, cidofovir, and foscarnet to inhibit HCMV
replication is typically followed by vision loss in the contralateral eye within one year [15,21].
Vision loss occurs due to HCMV infection in dendritic cells and macrophages in the bone
marrow exiting the latency stage to reactivate within the nucleus, through HCMV detaching from
the IE promotor gene. Production of new infectious viral particles can now take place. The
advantage the virus has to sustain virulence is due to the challenge of the immune system to
detect limited viral genes within the cells. Therefore, the infected host myeloid progenitors cells
divide as usual and differentiate into monocytes spreading the virus further [15].
During HCMV retinitis, the virus enters into the RPE through endocytosis resulting in
full-thickness retinal necrosis and retinal hemorrhage [22]. The shrewdness of this virus utilizes
viral protein products to prevent antigen presentation from traveling in the blood undetected by
cytotoxic T cells and avoid attack [22]. HCMV also created a HLA class 1 homolog to remain
unrecognized by natural killer cells (NKC), since NKC adapt a way to detect downregulation of
HLA class 1 [22]. Furthermore, HCMV will bind a created cytokine homolog to the host’s
receptor, such as IL-10, to downregulate the immune response and prevent signaling of CD4+ T
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cells. The mechanisms of blindness caused by HCMV retinitis involves the destruction of the
retina, retinal detachment, uveitis, and damage to the fovea, observed in Figure 2.

Figure 2. Photograph of a Posterior View of a Human Eye through an Ophthalmoscope.
(A) Healthy patient. Optic nerve and fovea are intact with no retinal destruction observed. (B)
Fundus of an eye in an AIDS- related HCMV retinitis patient. Morphology shows the
continuation of retinal destruction, retinal hemorrhages, white granular foci, vascular sheathing,
and panuveitis.
AIDS-related HCMV retinitis progresses after an immunocompromised host succumbs to
a significant decrease in their T lymphocytes. The expansion of ART within the United States to
stabilize the HIV/AIDS pandemic as well as increase T lymphocytes has lowered a substantial
amount of HCMV retinitis cases within the last decade [22]. Nevertheless, ART is not a drug that
is consistently available worldwide, which condemns HIV patients outside of the United States.
Moreover, individuals within the United States suffer from ineffective responses to ART. The
inconvenient access to ART medication, quality of life, and cost that is associated with
immunotherapy will increase the burden on AIDS-patients as well as the health care system.
Finding enhanced methods to prevent the disease is both essential for improving economic
burdens as well as the health of the population. The mechanisms as to how HCMV retinitis
progresses in AIDS patients is vital for treatment improvement and vision loss prevention.
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1.2

The Human Retina
The human retina is an immune-privileged site acting as an extension of the brain through

the optic nerve located in the posterior segment of the globe of the eye [23]. The retina is
composed of 10 layers listed in order from the layer touching the vitreous humor to the Bruch’s
membrane: the inner limiting membrane (ILM), nerve fiber layer (NFL), ganglion cell layer
(GCL), the inner plexiform layer (IPL), the inner nuclear layer (INL), the outer plexiform layer
(OPL), the outer nuclear layer (ONL), the outer limiting membrane (OLM), the photoreceptor
layer (PL), and lastly the RPE. A visual representation of the position of the retinal layers in the
eye is displayed in Figure 3.

Figure 3. Human Eye Globe and Cell Layers of the Huma Retina. (a) A sagittal view of the
brief anatomy of a human eye and (b) the Diagram of its respective retinal layers [24].
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There are no resident inflammatory cells within the retina; therefore, the retina does not
elicit a typical inflammatory immune response. The blood supply of a human neurosensory retina
comes from the retinal artery that enters the eye through the optic nerve. The retinal artery
branches off into a capillary network to form a blood-ocular barrier. The blood-ocular barrier
allows the movement of macrophages and leukocytes through the Bruch’s membrane to perfuse
between the RPE. However, the RPE blood flow is supplied by the choroidal vessels and can
assist in the transfer of leukocytes into the remaining layers of the retina [58].
The RPE functions as the main defense layer of the retina. A physiological advantage of
the RPE is how it contains tight junctions at the apex of its cells to regulate molecules coming
into the retina. Another purpose of the RPE is its role as a blood-retinal barrier between the
photoreceptor cells and the Bruch’s membrane. In the event of an inflammatory response, tight
junctions uncouple to allow access of macromolecules to diffuse between the RPE and the bloodretinal barrier.
The RPE is a pigmented cell monolayer layer that has several functions to help provide
nourishment, support, and protection to the photoreceptor cells to maintain visual acuity in the
host. Photoreceptors detect light and transmit signals through several neurons into the ganglion
cell, which exits through the optic nerve for visual processing in the brain. The photoreceptors
are located on the apical side of the RPE as it sheds its outer segment daily. Part of the RPE
function is to phagocytose the daily shed of the segments and regulate the flow of ions to the
photoreceptors for phototransduction.
The RPE is essential for retinal homeostasis, transporting nutrients [25], and removing
waste from the photoreceptor cells [26]. In the retina, the RPE is of main concern compared to
the other retinal layers due to its high concentration of mitochondria to supply energy to
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continually carry out these cell protective functions [27]. In addition to its vital properties, cell
dysfunction or cell death of the RPE is fatal for vision because the choroidal blood supply to the
photoreceptors will be lost as well as.
1.3

Reactive Oxygen Species
One factor suspected to accelerate the progression of HCMV retinitis is the increase in

oxidative stress within the RPE caused by the accumulation of reactive oxygen species (ROS).
ROS are natural byproducts of the mitochondria [28]. ROS molecules, also labeled as free
radicals, are derived from molecular oxygen in the electron transport chain (ETC)/ oxidative
phosphorylation metabolic pathway during aerobic respiration [30]. In the case of cellular stress
in the RPE, the cell will increase its ATP output by its need to increase its cellular defense
mechanism [31]. Thus a faster production of ATP establishes a higher chance of error that
increases the output of ROS, which is why ROS serves as a signal molecule for cellular stress
[29].
Oxidative phosphorylation is the key generator of the potential detriment to the retina due
to an over-accumulation of ROS molecules [31,32]. The generation of a superoxide ion, is within
the mitochondrial matrix and dependent on the proton motive force within the inner
mitochondrial membrane. Many free radicals are formed from the imbalance of the redox
reaction of superoxide [28]. CoEnzyme Q, the NADH/NAD+ complex, and ratios of molecular
oxygen already present surrounding the ATPase in the inner mitochondrial membrane are
involved in free radical formation [28]. A diagram that depicts free radical formation is shown in
Figure 4.
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Figure 4. ROS production from the electron transport chain in the Inner Mitochondrial
Membrane. Tricarboxylic acid (TCA), nicotinamide adenine dinucleotide (NADH and NAD+),
flavin adenine dinucleotide (FADH2 and FAD), (adenosine diphosphate) ADP, adenosine
triphosphate (ATP), coenzyme Q (Co Q), cytochrome c (cyt c), uncoupling protein (UCP) [29,
33].
The most prevalent form of ROS is hydrogen peroxide serving as a precursor molecule to
many of the free radical species. ROS aggressively increases when the cell is put under highly
stressful conditions [31]. When the RPE undergoes stress from incidences such as viral infection,
excessive light exposure, or complications due to natural aging, the RPE accelerates its
mitochondrial function for more ATP to restore homeostasis in the retina. The ATPase rotates
more frequently to join more ADP and phosphate groups together, which leads to a higher
byproduct amount of unreduced free radicals producing more ROS. Epithelial cells possess a
natural defense against naturally occurring ROS molecules known as antioxidants. Antioxidants
are present to reduce free radicals through redox reactions, converting free radicals to water.
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There are many antioxidants present, but common molecules studied in the cell are
glutathione peroxidase (GPx), glutamate-cysteine ligase (GCLC), superoxide dismutase 3
(SOD3), and nuclear factor erythroid 2-related factor 2 (NRF2). GPX is an antioxidant that
converts hydrogen peroxide to water [34]. SOD3 detoxifies the environment by decreasing the
number of free radicals in the retinal environment [35]. Nrf2 is a transcription that further lowers
toxicity by reducing the reactivity of ROS molecules [35]. When the number of free radicals
outnumber the available antioxidants in the cellular environment, it increases toxicity within the
cell. Under high concentrations of ROS, RPE is at an increased risk for cell death due. ROS is
capable of degrading cell membranes, reducing the formation of ATP, reacting with
phospholipids inducing inflammation by creating a permeable membrane, and decrease
metabolic function [30],[36].
Mitochondrial degeneration within the RPE diminishes RPE function and, in return, causes
a breakdown of photoreceptor cells due to loss of defensive aid [26, 36, 37]. Increased ROS
species leads to decreased membrane density within the RPE and cell death, such as necroptosis
within the cell [28, 36].
1.4

RIPK3 Influence
RIPK3 is an essential molecule for tissue repair and inflammation brought on from injury

in the cell [47]. RIPK3 kinase activity can mediate necroptosis activity and cytokine expression
[47]. The scaffolding function of RIPK3 has added speculation in previous literature for its
involvement in non-necrotic RIPK3 signaling mediated by oxidative stress [47].
Necroptosis is an alternative programmed pathway induced when caspase-8 activity is
blocked. RIPK3- dependent necroptosis is mediated by RIPK3 (receptor-interacting
serine/threonine-protein kinase) and will cause swelling, membrane lysis, and ATP depletion in
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the cell. RIPK1 recruits RIPK3 through its RIP homotypic interaction motif (RHIM) to activate
RIPK3. Activated RIPK3 phosphorylates mixed lineage kinase domain-like (MLKL) molecule to
form an oligomer complex with other phosphorylated MLKL molecules. The MLKL oligomer
complexes migrate to the plasma membrane to rupture the cell membrane through pore
formation and cause cell lysis [38, 39]. The release of cellular contents such as damageassociated molecular patterns (DAMPs) recruits a highly pro-inflammatory response, which
further progresses the cell death cycle [38]. Previous data have shown that necroptosis markers
were upregulated in RPE cells under high oxidative stress [36].
Furthermore, in vitro studies had revealed a significant increase in RPE viability when
necroptosis was inhibited, confirming it is the leading cell death pathway occurring in oxidative
stressed RPE cells [36, 40]. An increase of oxidative stress concentration in the RPE upregulates
necroptosis as a cellular defense response to protect the health of the retina [36].
ROS can play a role in the signaling functions of non-necrotic RIPK3 [4]. More work is
necessary to identify the different role ROS plays in necrosis-independent RIPK3 signaling,
including the different antioxidant effects [4].
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Table 1. Molecules Mediated by RIPK3 Opposed to RIPK3-Dependent Necroptosis
Molecules Mediated/
Effected by RIPK3

Overview of Regulatory Factors and Mechanism
Involved

TNF

RIPK3 may serve as a control for TNF-induced necrosis
by switching TNF mediated cell death from apoptosis to
necroptosis [47].

IKK α/β

IKK α/β phosphorylate RIPK1 to block the formation of
RIPK1-RIPK3 complex

TRAF-2

TRAF-2 inhibits necroptosis by binding to MLKL to
block RIPK3 and MLKL interaction

NF-κB

NF-kappaβ is a latent transcription factor that effects
RIPK3 in cell injury and during innate inflammatory
responses. NF-κB can negatively control RIPK3dependent necroptosis. For example, in response to TLR
stimulation, NF-κB brings about inflammatory cytokine
expression [47].

p38- MAPK

p38-MAPK pathway suppresses RIPK3 activation [48]

DC (dendritic cells)

RIPK3-independent mechanisms can regulate DC and
cause inflammation [47].

IL-23 and IL-1β

RIPK3 controls IL-22 expression through stimulation of
IL-23 and IL-1β. RIPK3 allows IL-1β processing in
dendritic cells and macrophages. RIPK3 dependent
necroptosis and IL-1βare induced by the ablation of
caspase 8 [49].

K48-linked
Polyubiquitination

K48-linked to the kinase domain within RIPK3 through
polyubiquitination inhibiting necroptosis causing RIPK3
to be rapidly degraded by proteasomes

DAI (DNA-dependent
activator of IFN-regulatory
factors)

RIPK3 may trigger necroptosis through the influence of
DAI and RIPK1

C-terminal RHIM

C-terminal RHIM-containing cleavage product of RIPK3
was shown to induce non-necrotic cell death, while the Nterminal kinase domain-containing product was unable to
trigger any form of cell death
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FADD

RIPK3 can function as a pro-apoptotic converter to recruit
RIPK1 and FADD. The interaction will lead to the
activation of caspase-8 and subsequently, apoptosis

Table 1. Molecules Mediated by RIPK3 Opposed to RIPK3-Dependent Necroptosis.

Taking everything into account, RIPK3 has demonstrated the ability to be activated
independent of necroptosis, as well as mediate necroptosis. Therefore, with the RPE primary
function as the caretaker of the retina to protect against cellular stress, this gives a plausible
reason why we should continue the investigation of RIPK3 influence through ARPE-19 cell cells
[54].
ARPE-19 cells are a spontaneously arising pigmented epithelial human cell line which were
created by selective trypsinization of a primary RPE from a 19-year old male. The cell culture
shows normal structure and function of the cell nuclei similar to human RPE (hRPE). The cell
line exhibits stable cell replication and resulted in a uniform replication similar to hRPE [16].
The ARPE-19 monolayer cells were proven to be a reliable cell line by evaluation of tight
junction formation, morphology, and structural properties, for in vitro studies [62, 64].
Regardless of the success of these studies [16,18], we cannot ignore that ARPE-19 cells are a
transformed cell line and leave the opportunity not to portray a 100% accurate depiction of what
will occur in hRPE [63].
HCMV replication has proved to cause an imbalance of the oxidant/antioxidant ratio,
increasing the production of ROS [6], and in the RPE, oxidative stress can cause necroptosis.
Although HCMV inhibits RIPK3-mediated necroptosis, the upregulation of RIPK3 in the RPE
led us to pursue our hypothesis, (1) HCMV-infected ARPE-19 cells will upregulate RIPK3 in
the presence of oxidative stress induced by H2O2. HCMV exhibits cell-specific pathogenesis.
Hence, to determine if stimulation of RIPK3 is cell-specific to ARPE-19 cells, we decided to
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compare our future findings to another cell type. HCMV establishes viral tropism for fibroblasts
and endothelial cells [58]. Since, fibroblast cells are not found in the eye we decided to use a
fibroblast cell line, MRC-5 cells as a comparison. Therefore, our second hypothesis tests (2)
HCMV-infected MRC-5 cells will not express RIPK3 stimulation in the presence of
oxidative stress induced by H2O2.

2
2.1

MATERIALS AND METHODS

Cell Culture
ARPE-19 cell line was purchased from ATCC (Manassas, VA, No. SCRC-1002) and was

passaged (TC-MCMV) in 75-cm2 flasks in growth media Dulbecco’s modified eagle media F-12
(DMEM, Corning Life Sciences, Manassas, VA, #10-013) supplemented with 10 % fetal bovine
serum (FBS, Atlas Biologicals, Fort Collins, CO, #FR-0500-A), 0.5 mM sodium pyruvate, 50
U/mL penicillin/50 mg/mL streptomycin, and 4 mM L-glutamine. MRC-5 cells were acquired
from ATCC and grown in a base media of DMEM in 10% fetal bovine serum (FBS) media
supplemented with gentamicin, sodium bicarbonate, and penicillin. T-75 flasks were replaced
with new media every 2 days to sustain cellular health. Cells were maintained at 37°C and 10%
CO2. Single layer confluent cells were grown in 12-packs for in vitro viral infection of HCMV
treated with hydrogen peroxide concentrations 100mM, 200mM, and 300mM in the appropriate
ARPE-19 and MRC-5 media stated above.
2.2

Viral Stock
Human cytomegalovirus, Towne strain, was disseminated and quantified in MRC-5 cells

stored at -80° C. MRC-5 cells were infected from a clarified viral stock; frozen, thawed, and
propagated until the cytopathic effect increased to a MOI of 5. All experiments for viral infection
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in ARPE-19 cells were performed using ARPE-19 cell media maintained in a 1:1 mixture of
Dulbecco’s modified eagle media F-12 (DMEM), with 10 % fetal bovine serum (FBS), 0.5 mM
sodium pyruvate, 50 U/mL penicillin/50 mg/mL streptomycin, and 4 mM L-glutamine. All
experiments for viral infection in MRC-5 cells were performed using the appropriate MRC-5 cell
media maintained in a 1:1 mixture of DMEM in 10% fetal bovine serum (FBS) media
supplemented with gentamicin, sodium bicarbonate, and penicillin.
2.3

RNA Extraction from Cell Monolayers
Cell monolayers experimentally treated as specified were harvested at indicated time

points in TRIzol® reagent (Ambion/ThermoFisher). Total RNA was isolated by chloroform
extraction, purified over PureLink® RNA Mini Kit spin cartridge filters according to the
manufacturer’s instructions (Ambion/ThermoFisher), and stored frozen at -80°C until use in
downstream applications.
2.4

Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction
ARPE-19 cells and MRC5 cells were harvested in 0.5 mL of Trizol reagent (Invitrogen

Life Technologies) at 1, 2, and 4 hour-post-infection (hpi). Continued harvest in 0.5 trizol at 1, 2,
3, 4, 5, and 6 day-post-infection (dpi). Complete RNA was isolated by chloroform and purified
using reagents in the PureLink® RNA Mini Kit spin cartridge filters acquired from
Ambion/Thermo-Fisher Scientific. RNA was reverse- transcribed into cDNA using SuperScript
III first-strand synthesis system. Real-time RT-PCR procedure was done using Applied
Biosystems 7500 Fast Real-Time PCR System and using a Power SYBR Green Master mix.
Human specific primers for RIPK1, RIPK3, MLKL, and Nrf2 were obtained from QIAgen.
Housekeeping gene GAPDH was used to normalize analysis and mRNA fold change was
determined using the 2-ΔΔCt method.
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2.5

Statistical Analysis
All quantitative data for Real-time RT-PCR assays were performed from at least two

independent experiments compared to the control with +/- standard deviations. Statistical
analyses were performed using GraphPad Prism and analysis of variance were performed
through two-way ANOVA with p values; *p < 0.05; **p < 0.001 considered significant.

3

RESULTS

RIPK3 STIMULATION IN HCMV-INFECTED OXIDATIVE STRESSED ARPE19 CELLS

Hypothesis (1) tested that HCMV-infected ARPE-19 cells will upregulate RIPK3 in the
presence of oxidative stress induced by H2O2. Commonly, when RIPK3 activation is observed,
necroptosis is the leading cell death pathway to account for this cellular degradation. HCMV has
shown to inhibition of necroptosis [6], but also requiring fatty acid synthesis and histone
methylation for replication. An increased amount of ROS induces oxidative stress and depletes
both fatty acid synthesis and histone methylation in a cell [68]. An abundant amount of ROS
found in ARPE-19 has shown an increased level of RIPK3 in ARPE-19 cells. RIPK3 is an
essential molecule for tissue repair and inflammation brought on by cell injury [47]. RIPK3 can
mediate necroptosis activity and non-necrotic signaling induced by oxidative stress [47].
Therefore, in this study we performed qPCR to test mRNA expression of RIPK1, RIPK3,
MLKL, Nrf2, SOD3, GCLC, and GPX-1. To investigate if HCMV-infection and oxidative stress
in ARPE-19 cells stimulates RIPK3 as synergistic or additive effect.
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3.1

mRNA expression of RIPK3 in HCMV-infected ARPE-19 cells.
To begin, in determining if RIPK3-mediated necroptosis is the cell death pathway at

work during early HCMV-infection in ARPE-19 cells, we tested mRNA levels of key
necroptosis markers: RIPK1, RIPK3, and MLKL.

Figure 5. mRNA expression of RIPK3 in HCMV infected ARPE-19 cells. ARPE-19 cells
were harvested at 0 hpi, 1 hpi, 2 hpi, 4hpi, 1 dpi, 2 dpi, 3 dpi, 4 dpi, 5 dpi, and 6 dpi. HCMV
(Towne strain) at a MOI=5. These samples were accessed through mRNA expression of RIPK3mediated necroptosis markers RIPK1, RIPK3, and MLKL through RT PCR and compared back
to the media- treated control. All three experimental repeats were performed on different days
with the same time points. * p<0.05 and ** p<0.01 all samples
There is a prominent fold change of increased RIPK3 mRNA expression seen at 1 hpi
and 4 hpi. RIPK3 stimulation continues over 2 days post-infection, then quickly decreases for the
reminder of the tested time points. There is a decline of RIPK3 shown at 2 hpi, while mRNA
expression of RIPK1 and MLKL show minimal increased stimulation in response to HCMVinfection in ARPE-19 cells. To confirm RIPK3-mediated necroptosis as the leading cell death
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pathway all three markers are expected to be upregulated. Therefore, based off Fig. 5. we cannot
assume RIPK3-mediated necroptosis is an active mechanism at work in RPE HCMV- infection
over 6 days, but it may be a mechanism that is initiated by the cell during early-onset infection.
3.2

mRNA expression of Antioxidant Markers in HCMV infected ARPE-19 cells.

In addition to our findings, we tested four antioxidant molecules that may be involved in
RIPK3- independent mechanisms and/or oxidative stress. If there is an increase or decrease of
these markers in HCMV-infection without hydrogen peroxide treatment, it may lead us closer to
answering why there is an pronounced increase of RIPK3 [10].

Figure 6. mRNA expression of Antioxidant Markers in HCMV-infected ARPE-19 cells.
HCMV (Towne strain) MOI=5 infected ARPE-19 cells. All three experimental repeats were
infected and harvested at the same time points. mRNA expression of GPX-1, GCLC, SOD3, and
Nrf2 were all compared back to media- treated control cells. * p<0.05 and ** p<0.01 all samples.
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There were little to no stimulation of GPX-1, GCLC, or SOD3 at these specific time
points tested. However, there is an increased activity of Nrf2 mRNA expression shown over 2dpi then declined for the remainder of the time course.
3.3

mRNA Expression of Necroptosis Markers and Nrf2 in HCMV-infected ARPE-19
Cells from 1 to 4 hours.
RIPK3 presents a high fold change at 1-hpi, 4-hpi, but immediately declines at 2-hpi

throughout our experimental repeats. Our next step was to investigate the stimulation of these
markers over a shorter time frame (4 hours), where we saw the most engaging activity of RIPK3.

Figure 7. mRNA Expression of Necroptosis Markers and Nrf2 in HCMV-infected ARPE-19
cells from 1 to 4 Hours. HCMV (Towne strain) MOI=5 infected ARPE-19 cells all infected at
the same time and harvested at the same time points. * p<0.05 and ** p<0.01, HCMV groups
were compared back to the media-treated control.
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RIPK1 shows no stimulation during the first four hours of HCMV-infection in ARPE-19
cells. While RIPK3 shows repeated results compared to, Fig. 5. through a consistent pattern of
upregulation at 1 hpi, a decline at 2 hpi, and an increase at 4 hpi. MLKL and Nrf2 show a
moderate increase at 1 hpi, but proceeds to decrease for the remaining 4 hour time period. We
know based on our repeated results in Fig 6. that there will be another increase of Nrf2 in 2 days.
Nrf2 is usually a molecule in cellular senescence; this peak at 1 hpi suggests it serves as either an
aid or a hindrance to HCMV survival upon early infection.
Furthermore, since RIPK3 has shown consistent upregulation in mRNA expression upon
early infection, we needed to compare these findings to cells without HCMV-infection. In
addition to testing the stimulation or suppression of RIPK1, RIPK3, MLKL, and Nrf2 in an
oxidative stressed cellular environment. Hydrogen peroxide is the main byproduct of a redox
imbalance, causing oxidative stress in the cell. Therefore, we simulate an oxidative stressed
environment in a cell through a building concentration of hydrogen peroxide. Therefore, we
performed qPCR on mock-infected ARPE-19 cells to test RIPK1, RIPK3, MLKL, and Nrf2 in
different concentrations of hydrogen peroxide.
3.4

Mock-Infected ARPE-19 cells Treated with Different H2O2 Concentrations
We treated ARPE-19 cells with 100mM, 200mM, and 300mM concentrations of hydrogen

peroxide to investigate whether stimulation of RIPK3 is also dose-dependent. Since cell death
mechanisms are dependent on molecular influence, cell type, and cellular environment [11, 12],
we considered it essential to continue testing for necroptosis markers RIPK1 and MLKL, in
addition to Nrf2.
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Figure 8. Mock-Infected ARPE-19 cells Treated with Different H2O2 Concentrations.
APRE-19 samples treated with 100mM, 200mM, and 300mM H2O2 solutions were all harvested
at the same time for all respective time points. All experiments were compared back to the media
control.
RIPK1 mRNA expression presented a moderate increase at 1 hpi in treated 200mM and
300mM hydrogen peroxide concentration, but declined for the remainder time period. MLKL
mRNA expression was upregulated at 1 hpi in 200mM hydrogen peroxide treatment and showed
little to no stimulation under the other concentrations over time. Nrf2 mRNA expression showed
a moderate increase in 300mM hydrogen peroxide treatment at 1 hpi, with no stimulation in the
other concentrations over time. The only increase of mRNA RIPK3 expression at 1 hpi was in
300mM hydrogen peroxide treatment, with a repeated downregulation at 2 hpi.
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In mock-infected ARPE-19 cells, RIPK1, MLKL, and Nrf2 mRNA expression do not
show a pattern of increase or decrease treated with varying hydrogen peroxide concentrations.
However, RIPK3 mRNA expression does present an increase dependent on the concentration of
hydrogen peroxide. In cells treated with a lower concentration, 100mM, RIPK3 increase occurs
at a later time point, while treated with a stronger concentration, 300mM, RIPK3 increases
sooner at 1 hpi.
Furthermore, since RIPK3 has shown a dose dependent relationship treated with
hydrogen peroxide our next consideration was to test the same markers in the prescence of
HCMV. We treated HCMV-infected ARPE-19 cells with hydrogen peroxide concentrations of
100mM, 200mM, and 300mM to test if RIPK3 stimulation is dose-dependent. Studies have
found HCMV to have stimulated replication due to treatment of exogenous hydrogen peroxide in
another cell type [49]. Since cell death mechanisms are dependent on molecular influence, cell
type, and cellular environment [53, 54], we considered it essential to continue testing for
necroptosis markers RIPK1 and MLKL, in addition to RIPK3. Subsequently, while seeing an
increase of Nrf2 in Fig 7. we continued qPCR testing of this marker to observe it’s stimulation
under oxidative stress.
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HCMV- Infected ARPE-19 Cells Treated with Different Concentrations of H2O2.
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Figure 9. HCMV-infected ARPE-19 cells Treated with Different Concentrations of
H2O2. HCMV (Towne strain), MOI=5, infected ARPE-19 cells all infected at the same
time and harvested at the same time points. ARPE-19 samples with 100mM, 200mM, and
300mM H2O2 solutions were treated and collected at the same time for all time points.
All experiments were compared back to the media control.
RIPK1 and Nrf2 mRNA expression show little to no stimulation in hydrogen peroxide
treatment. Similar to the results in mock-infected cells, in Fig. 8, at 4 hpi in 300mM hydrogen
peroxide treatment, there is a decline in RIPK3 expression and an increase in 100mM
concentration. Exhibiting a dose dependent relationship between RIPK3 during HCMV
infection. In cells treated with 100mM and 200mM hydrogen peroxide, there is a dampening
effect of RIPK3 mRNA expression in HCMV-infection. Suppression of RIPK3 favors HCMV
survival. In 300mM hydrogen peroxide treatment RIPK3 is decreased at 1 hpi compared to
mock-infected cells in Fig. 8. This decrease of RIPK3 would no longer be in favor of host cell
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survival and will aid in prolonging AIDS-related HCMV retinitis. At 2 hpi there is no increase of
RIPK3 in all hydrogen peroxide concentrations. MLKL mRNA shows moderate stimulation at 1
hpi in a stimulation pattern dependent on the dose of hydrogen peroxide. The higher the
concentration of hydrogen peroxide, the more robust MLKL mRNA expression present at 1 hpi
becomes. As time progresses, the inverse reaction occurs where the lowest dose of hydrogen
peroxide causes a higher stimulation of MLKL compared to the highest concentration of
hydrogen peroxide.
3.6

RIPK3 Stimulation in HCMV-infected and Mock-infected ARPE-19 cells with H2O2
treatment.
Through our studies, we have determined RIPK3 stimulation is dose-dependent on

hydrogen peroxide concentration in HCMV-infection over time. To show this comparison, we
plotted our repeat experiments of only RIPK3 stimulation in HCMV-infected ARPE-19 cells to
mock-infected ARPE-19 cells within each graph. Our graphs below create a better presentation
of how the upregulation of RIPK3 is either sustained or dampened at specific hydrogen peroxide
concentrations. We tested mRNA expression through qPCR of RIPK3 at 100mM, 200mM, and
300mM H2O2 at 1 hpi, 2 hpi, and 4 hpi.
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Figure 10. RIPK3 Stimulation in HCMV-infected and Mock-infected ARPE-19
cells with H2O2 treatment. HCMV (Towne strain) MOI=5 infected ARPE-19 cells all
infected at the same time and harvested at the same time points. APRE-19 samples
with 100mM, 200mM, and 300mM H2O2 solutions were treated and harvested at the
same time for all time points. All experiments were compared back to the media
control.
We notice a repeated pattern at 1 hpi, where RIPK3 mRNA expression is
upregulated during HCMV-infection. When low concentrations of hydrogen peroxide (100mM
and 200mM) is present in the cell RIPK3 shows a prominent decrease. While, in ARPE-19 cells
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treated with 300mM hydrogen peroxide RIPK3 no longer shows a higher expression compared
to HCMV alone.
At 2 hpi there is again no prominent activity of RIPK3. Although the addition of 100mM
H2O2 does present a lesser expression of RIPK3 compared to the expression in HCMV alone
without H2O2, there is not a prominent difference.
At 4 hpi RIPK3 upregulation shows a fascinating presentation. As the same in Fig. 5. and
Fig. 7. upon HCMV-infection alone RIPK mRNA increases, but with the addition of 100mM
H2O2 there is a higher fold change in RIPK3. A higher fold change in mock-infected cells agrees
with the ARPE-19 cell’s natural response to activate a mechanism to repair cellular damage.
Although for cells infected with HCMV and H2O2 no longer seems to be an aid to the virus in
suppressing RIPK3- mediated mechanisms to sustain virulence. While at 200mM and 300mM
H2O2 (simulating oxidative stress building within the cell), hydrogen peroxide appears to work
back in HCMV favor and suppressing RIPK3. Therefore, RIPK3 mRNA expression exhibits a
dose-dependent response over time in HCMV-infected ARPE-19 cells in 100mM, 200mM,
and 300mM H2O2 concentrations.
3.7

Nrf2 Stimulation in HCMV- infected and Mock-Infected ARPE-19 cells treated with
H2O2.
Next, was to determine if there is a pattern shown in Nrf2 mRNA expression by

observing each fold change over 100mM, 200mM, and 300mM hydrogen peroxide
concentrations as we tested for RIPK3 mRNA expression.

Fold Change Over Media Control
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Figure 11. Nrf2 Stimulation in HCMV-infected and Mock-infected ARPE-19 cells.
HCMV (Towne strain) MOI=5 infected ARPE-19 cells were all infected and harvested at
the same time. ARPE-19 samples treated with 100mM, 200mM, and 300mM H2O2
solutions were treated and harvested at the same time for all time points. All experiments
were compared back to the media control.
At early onset, HCMV-infection of Nrf2 mRNA expression is decreased when hydrogen
peroxide is added to HCMV-infected ARPE-19 cells. The Nrf2 marker that would typically be
stimulated indirectly upon HCMV-infection is now suppressed in the presence of high oxidative
stress in the cell. After 1 hpi expression Nrf2 declines, but based on Fig. 5. we know that Nrf2
will be peak again at 2 dpi.
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RIPK3 STIMULATION IN OXIDATIVE STRESSED HCMV-INFECTED MRC-5
CELLS
Human fibroblasts are a target of HCMV replication [13, 14]. From our previous results in
Fig. 5.- Fig.10., RIPK3 stimulation in ARPE-19 cells were evident, so to determine if RIPK3
stimulation is cell-specific to APRE-19 cells, we tested the same variables on MRC-5 cells. To
determine if stimulation of RIPK3 is cell-specific to ARPE-19 cells, we decided to test identical
variables in another cell type. We took into account the other pathologies HCMV has in different
cell types, such as fibroblasts and endothelial cells. Therefore, we decided to use a fibroblast cell,
MRC-5, that has tropism for HCMV as well as not found in the eye to confirm our results.
Leading our second hypothesis to test that (2) HCMV-infected MRC-5 cells will not express
RIPK3 stimulation in the presence of oxidative stress induced by H2O2.
We began by performing qPCR to observe if there would be a baseline upregulation of
RIPK3 in early hours of HCMV-infection in MRC-5 cells. We continued testing RIPK1 and
MLKL markers to discern if RIPK3-mediated necroptosis was the mechanism at work and if not,
would Nrf2 play a role in RIPK3 rising out of a quiescence state.
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3.8

mRNA Expression of Necroptosis Markers and Nrf2 in HCMV-infected MRC-5 cells.

Figure 12. mRNA Expression of Necroptosis Markers and HCMV-infected MRC-5
cells. HCMV (Towne strain) MOI=5 infected MRC-5 cells were all infected and harvested
at the same time for respective time points post-infection. * p<0.05 and ** p<0.01, HCMV
groups were compared back to the media-treated control. All samples in all 4 graphs were
**p<0.01.
There was no stimulation in MRC-5 cells of RIPK3, RIPK1, or MLKL at these time points tested
in early HCMV-infection. Nrf2 was the only molecule tested that showed a stimulation at 4 hpi.
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3.9

mRNA Expression of Necroptosis Markers and Nrf2 in Mock-Infected MRC-5 Cells

Figure 13. mRNA Expression of Necroptosis Markers and Nrf2 in Mock-Infected MRC-5
Cells. All MRC-5 samples treated with 100mM, 200mM, and 300mM hydrogen peroxide
solutions were harvested at the same time for all respective time points. All experiments were
compared back to the media control and **p<.01 significant.

Furthermore, even under the tested hydrogen peroxide concentrations in mock-infected
MRC-5 cells, RIPK1, RIPK3, MLKL, and Nrf2 did not display a significant stimulation of either
markers.
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3.10 Necroptosis and Nrf2 mRNA Expression in HCMV-Infected MRC-5 Cells Treated
with Different Concentrations of H2O2

Figure 14. Necroptosis and Nrf2 mRNA expression in HCMV-infected MRC-5 Cells
treated with Different Concentrations of H2O2. HCMV (Towne strain), MOI=5,
infected MRC-5 cells were all infected and harvested at the same time points. MRC-5
samples treated with 100mM, 200mM, and 300mM H2O2 solutions were treated and
harvested at the same time for all time points. All experiments were compared back to the
media control and **p<.01 significant.
RIPK1, RIPK3, and MLKL did not show an increase in any tested hydrogen peroxide
concentrations in HCMV-infected MRC-5 cells. This is an important support for the stimulation
of RIPK3 found in APRE-19 cells proving the RIPK3 stimulation is cell-specific.
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3.11 RIPK3 mRNA Expression in HCMV-Infected MRC-5 Cells Treated with Different
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Figure 15. RIPK3 mRNA Expression in HCMV-Infected MRC-5 Cells Treated with
Different Concentrations of H2O2. HCMV (Towne strain) MOI=5 infected MRC-5 cells
treated with 100mM, 200mM, 300mM hydrogen peroxide solutions were all infected and
harvested at the same time. * p<0.05 and ** p<0.01, all groups were compared back to the
media-treated control and **p<0.01 significant.
RIPK3 was not upregulated in MRC-5 cells during HCMV-infection, HCMV-infection
treated with hydrogen peroxide of the three tested concentrations, or in mock-infected MRC-5
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cells. To continue to see if this activity is cell specific to ARPE-19 cells we tested the mRNA
expression of Nrf2 under the same conditions.
3.12 Nrf2 mRNA Expression in HCMV-infected and Mock-infected MRC-5 cells under

Fold Change Over Media Control
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Figure 16. Nrf2 mRNA Expressoin in HCMV-infected and Mock-infected MRC-5 Cells
under Induced Hydrogen Peroxide at Several Concentrations. HCMV (Towne strain),
MOI=5. MRC-5 cells were treated with 100mM, 200mM, 300mM hydrogen peroxide
solutions and were all infected and harvested at the same time. * p<0.05 and ** p<0.01, all
groups were compared back to the media-treated control. All sample groups were **p<0.01
significant.
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Nrf2 only showed a moderate upregulation at 1 hpi under 200mM hydrogen peroxide
concentration. Aside from the slight stimulation at 1 hpi, increasing hydrogen peroxide
concentration displayed no upregulation when compared back to media during the first 4 hours
of acute infection.

4

DISCUSSION

Two hypotheses were tested to broaden our understanding of RIPK3 activity during
HCMV-infection amongst oxidative stress present in the RPE. Hypothesis (1) tested that
HCMV- infected ARPE-19 cells will upregulate RIPK3 in the presence of oxidative stress
induced by H2O2. To validate cell specificity based on previous results, our second Hypothesis
tested that (2) HCMV-infected MRC-5 cells will not express RIPK3 stimulation in the presence
of oxidative stress induced by H2O2. As stated in the introduction, one of RPE functions is to
prevent or alleviate cell injury. Accumulation of hydrogen peroxide left untreated can result in
cell death. Despite HCMV showing inhibitory effects of RIPK3-mediated necroptosis, there is an
increase in RIPK3 activity during early infection, Fig. 5. It then became essential to determine
whether the two variables, HCMV and oxidative stress, influence on RIPK3 upregulation, were
additive or synergistic.
Without the addition of hydrogen peroxide in HCMV-infected ARPE-19 cells, RIPK3
increases during early infection, as shown in Fig. 5. and Fig. 7. at 1 hpi and at 4 hpi. When
hydrogen peroxide is added to HCMV-infected RPE cells, RIPK3 is decreased at 1 hpi. There is
also a noticeable difference in the sustained downregulation of RIPK3 in the 200 mM hydrogen
peroxide solution in Fig. 9. Therefore, we see that amongst an excessive accumulation of
hydrogen peroxide, there is a dampening effect of RIPK3 stimulation during early HCMV-
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infection. All things considered, this can lead to the reduction of RIPK3- mediated
necroptosis and RIPK3-independent mechanisms, which ultimately encourages HCMV
replication and sustain retinal destruction.
During the progression of AIDS-related HCMV retinitis, oxidative stress may be a factor
to influence host cell death by lessening a defense mechanism of the RPE. These findings and
related studies are essential in the accurate detection of which cell-defense markers are necessary
to be included as targets in antiviral therapies.
While it does not escape our attention that other antioxidants are present. The commonly
tested antioxidants such as SOD3, GCLC, and GPX-1, initially investigated in this study,
displayed inconsistent stimulation in mRNA expression to continue analysis during early
infection. We conclude that SOD3, GCLC, and GPX-1, markers are not adequate targets for
future investigation to improve antiviral therapies in cytomegalovirus retinitis patients.
Due to the pathogenesis of HCMV still under investigation, understanding the development
of this disease is imperative to develop safe, innovative, and effective treatments for the
prevention and management of AIDS-related HCMV retinitis. All HIV infected patients do not
elicit a positive response to ART. In addition to the ineffective response to the current drug
therapies for HIV/AIDS, antiviral drug-resistant of HCMV strains have emerged throughout the
study of this disease. Antivirals created such as ganciclovir, valganciclovir, cidofovir, and
foscarnet suppress HCMV through targeting its virus-encoded DNA and showed positive
suppression in HCMV-infected patients. Despite the hopeful responses during the early years of
antiviral treatment, viral mutations circumvent ganciclovir and valganciclovir attack through the
pUL97 kinase producing ganciclovir and valganciclovir- resistant HCMV strains. Therefore, it
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would behoove us to look into other target molecules that may indirectly initiate or maintain
viral replication.
For instance, another way activated HCMV indirectly sustains its viral replication may
occur as follows. As viral replication transpires in the cell, it induces cellular stress, including
stress on the endoplasmic reticulum (ER) [41]. Viral stress on the cell activates a host cell
survival response known as the unfolded protein response (UPR) [41]. UPR is enabled to remove
misfolded proteins, upregulate chaperones to reestablish homeostasis during oxidative stress, and
sustain cellular metabolic state [41]. A branch of the UPR system that becomes activated is
known as PERK (Protein R-like ER kinase). PERK functions as an adaptive response to modify
protein synthesis and induce KEAP1 (Kelch-like ECH-associated protein 1)[43, 55]. KEAP1 is a
protein that acts as an intracellular detector of free radicals/ ROS by releasing antioxidant Nrf2
into the cytoplasm. Nrf2 acts as an antioxidant to eradicate free radicals. As it begins its attempt
to diminish the oxidative stress on the cell, it in turn removes the molecules that are initially
activating the UPR system. HCMV may take advantage of this negative feedback loop and
continue replication.
Furthermore, within this mechanism, activated PERK phosphorylates eIF2α (eukaryotic
initiation factor 2). Phosphorylated eIF2α works in favor of viral replication. It enables the
Translation Attenuation mechanism, which safeguards proper transcription and translation to
continue viral replication [44]. This potential mechanism is demonstrated in the self-illustrated
pathway in Fig. 17. In summary, UPR’s primary responsibility to aid in cell survival may result
in support of HCMV survival through indirectly continuing viral replication and ultimately
progressing HCMV retinitis.
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Figure 17. The Indirect Sustained HCMV Replication through two Pathways. Through a
cell survival mechanism of UPR, HCMV has acquired yet another way to sustain its virulence.
Blue colored boxes represent one pathway, and the green represents the second pathway. The
connectivity point of these two pathways are illustrated through the blue-green box, which
describes PERK activation, insinuating the UPR mechanism can indirectly activate eIF2 through
phosphorylation and initiate HCMV replication.
Considering there are mechanisms indirectly enhancing viral replication, antiviral therapies
should improve its content to reduce the accumulation of free radicals causing oxidative stress in
the RPE and lessen the concentration of Nrf2 within the cell. Nrf2 is one of many antioxidants
synthesized to combat increased levels of ROS [45]. Thus, targeting Nrf2 levels would
potentially remove another favorable molecule for HCMV replication and lessen the progression
of vision loss in AIDS- related cytomegalovirus retinitis.
FUTURE DIRECTION
Although the SOD3, GCLC, and GPX-1antioxidants did not yield a successful result in
mRNA expression, we should not reject the notion that there are several other antioxidants
present that may be involved in enhancing HCMV replication in the RPE. However, due to the
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upregulation of Nrf2 it may be a new potential target molecule for further investigation in
allowing continued replication of HCMV in RPE cells. Furthermore, subsequent protein assays
are necessary to assess protein levels of the markers tested as added support of mRNA
expression [37][38].
Also, to continue comparison studies of RIPK3 stimulation in ARPE-19 cells and MRC-5
cells, future experiments should be performed together on the same day for all time points. Also,
in vivo studies can be done through using knockout RIPK3 -/- mice to test for any markers
provided in Table 1. The new markers would be tested to know which independent RIPK3mediated mechanism is at work during early HCMV-infection.
CLINICAL RELEVANCE
HCMV cytopathic effect in AIDS-related HCMV retinitis, reigns a persistent problem for
AIDS patients who do not have access or show a negative response to antiviral treatment. One
way AIDS-related HCMV retinitis can be inhibited is to stop replication of the virus through
effective HCMV antiviral treatment. Due to the pathogenesis of HCMV still under investigation,
antiviral drug-resistant strains of HCMV have emerged throughout the study of this disease.
Therefore, it is essential to continue investigation of target molecules that may indirectly initiate
or maintain viral replication.
Our findings suggest that hydrogen peroxide is a factor in limiting cell survival by lessening
a host cell defense mechanism mediated by RIPK3. HCMV initially, as seen in Fig. 7., showed
elevated RIPK3 mRNA expression at 1 hpi and 4 hpi. However, when HCMV infected ARPE-19
cells were treated with hydrogen peroxide, a molecule seen to increase RIPK3-mediated cell
death, RIPK3 expression was decreased at 1 hpi and 4 hpi. Due to this suppression, hydrogen
peroxide that was once an aid to host cell survival is now an aid to HCMV survival; essentially
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progressing retinitis. Future investigations should continue experiments related to RIPK3
stimulation during HCMV retinitis in vitro and in vivo. In addition to RIPK3, separate studies
can be done to see the effects of PERK in the UPR system and Nrf2 to see confirm if they play a
role in sustaining HCMV replication. These future findings will be essential to further our
knowledge of which cell-defense markers is HCMV manipulating to sustain life, so there can be
improvement in HCMV antiviral therapies.
5

CONCLUSION

Herein we tested our hypothesis, (1) HCMV-infected ARPE-19 cells will upregulate
RIPK3 in the presence of oxidative stress induced by H2O2. The results of this study suggest
the following conclusions:
(i)

In vitro infection of HCMV upregulated RIPK3 mRNA expression and
may facilitate independent RIPK3- mediated mechanism upon early
infection,

(ii)

RIPK3 stimulation presents a dose-dependent response given the tested
hydrogen peroxide concentrations,

(iii)

Within the first-hour post-infection, the more hydrogen peroxide present
in the cell inducing oxidative stress favors the host cell cellular defense
and increase RIPK3 expression, and

(iv)

As time progresses within 4 hours post-infection, and oxidative stress
increases, RIPK3 is downregulated favoring HCMV sustained replication,
leading to the reduction of RIPK3- mediated necroptosis and RIPK3independent mechanisms, which ultimately encourages HCMV replication
and sustain retinal destruction.
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Our second hypothesis pursued (2) HCMV-infected MRC-5 cells will not express
RIPK3 stimulation in the presence of oxidative stress induced by H2O2.
(i)

In vitro infection of HCMV did not stimulate RIPK3 and will not facilitate
independent RIPK3- mediated mechanism upon early infection, and

(ii)

Due to lack of stimulation of RIPK3, RIPK1, MLK, and Nrf2 in MRC-5
cells prove that our findings in ARPE-19 are cell-specific
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